TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Dala Vård & Vaccin AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
14,324
|
12,582
|
7,444 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
1,111
|
2,096
|
292 |
EBITDA |
1,145
|
2,176
|
378 |
Total assets |
3,073
|
3,428
|
1,550 |
Current assets |
2,731
|
3,051
|
1,090 |
Current liabilities |
1,495
|
1,535
|
1,131 |
Equity capital |
1,406
|
1,783
|
419 |
- share capital |
60
![]() |
60
![]() |
60 |
Employees (average) |
5
![]() |
5
|
4 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
45.8%
|
52.0%
|
27.0% |
Turnover per employee |
2,865
|
2,516
|
1,861 |
Profit as a percentage of turnover |
7.8%
|
16.7%
|
3.9% |
Return on assets (ROA) |
36.2%
|
61.1%
|
18.8% |
Current ratio |
182.7%
|
198.8%
|
96.4% |
Return on equity (ROE) |
79.0%
|
117.6%
|
69.7% |
Change turnover |
1,742
|
5,138
|
439 |
Change turnover % |
14%
|
69%
|
6% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
25%
|
33% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.